Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Accolade, Inc.
  6. Summary
    ACCD   US00437E1029

ACCOLADE, INC.

(ACCD)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/26/2021 11/29/2021 11/30/2021 12/01/2021 12/02/2021 Date
27.13(c) 26.58(c) 25.67(c) 24.34(c) 25.83(c) Last
433 871 880 365 996 027 1 043 733 803 115 Volume
-4.54% -2.03% -3.42% -5.18% +6.12% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 306 M - -
Net income 2022 -187 M - -
Net cash position 2022 177 M - -
P/E ratio 2022 -8,67x
Yield 2022 -
Sales 2023 401 M - -
Net income 2023 -145 M - -
Net cash position 2023 118 M - -
P/E ratio 2023 -11,9x
Yield 2023 -
Capitalization 1 722 M 1 722 M -
EV / Sales 2022 5,04x
EV / Sales 2023 4,00x
Nbr of Employees 2 300
Free-Float 96,3%
More Financials
Company
Accolade Inc. is a provider of personalized, technology-enabled solutions that helps people to understand, navigate, and utilize the healthcare system and their workplace benefits. The CompanyÔÇÖs customers are primarily employers that deploy Accolade in order to provide employees and their families members a single place to turn for their health, healthcare, and benefits needs. Its platform combines open,... 
More about the company
Ratings of Accolade, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about ACCOLADE, INC.
12/02Jefferies Starts Accolade at Buy with $33 Price Target
MT
11/29Accolade to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
GL
11/17Accolade expands world-class executive leadership team with marketing and customer succ..
PR
11/17Accolade, Inc. Expands World-Class Executive Leadership Team with Marketing and Custome..
CI
11/10Accolade to Participate in the Credit Suisse 30th Annual Healthcare Conference
AQ
10/18VC DAILY : Is This VC Cycle Virtuous or Vicious?
DJ
10/14ACCOLADE : to Showcase Personalized Healthcare for Employers and Health Plans at HLTH Bost..
PR
10/12VC DAILY : Is It All or Nothing for Founders?
DJ
10/12ACCOLADE : Brings WellRight's Corporate Wellness Programs into its partner ecosystem
PR
10/08ACCOLADE : Piper Sandler Adjusts Accolade PT to $45 From $60, Maintains Overweight Rating
MT
10/08ACCOLADE : Stifel Nicolaus Adjusts Accolade PT to $60 From $64, Maintains Buy Rating
MT
10/08ACCOLADE : Morgan Stanley Adjusts Accolade PT to $56 From $58, Maintains Overweight Rating
MT
10/08ACCOLADE : Needham Adjusts Accolade's Price Target to $56 from $68, Keeps Buy Rating
MT
10/08ACCOLADE : SVB Leerink Adjusts Accolade's Price Target to $52 from $58, Keeps Outperform R..
MT
10/08ACCOLADE : Credit Suisse Lowers Accolade's PT to $62 from $63, Says Fiscal H2 2022 Outlook..
MT
More news
News in other languages on ACCOLADE, INC.
10/07Accolade enregistre une perte plus importante au deuxième trimestre de l'exercice fisca..
10/07Accolade, Inc. fournit des prévisions de résultats pour le troisième trimestre se termi..
07/08Accolade réduit sa perte au premier trimestre et augmente son chiffre d'affaires, et re..
07/08Earnings Flash (ACCD) ACCOLADE affiche un chiffre d'affaires de 59,5 millions de dollar..
07/08Accolade, Inc. révise ses prévisions de bénéfices pour l'exercice financier se terminan..
More news
Analyst Recommendations on ACCOLADE, INC.
More recommendations
Chart ACCOLADE, INC.
Duration : Period :
Accolade, Inc. Technical Analysis Chart | ACCD | US00437E1029 | MarketScreener
Technical analysis trends ACCOLADE, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 13
Last Close Price 25,83 $
Average target price 54,42 $
Spread / Average Target 111%
EPS Revisions
Managers and Directors
Rajeev Singh Chairman & Chief Executive Officer
Robert N. Cavanaugh President
Stephen H. Barnes Chief Financial Officer
Harish Naidu Chief Technology Officer
Shantanu Nundy Chief Medical Officer
Sector and Competitors